|
Orthologous residues
|
|
ARHGAP5 (human): Y306‑p, ARHGAP5 iso5 (human): Y306‑p, ARHGAP5 (mouse): Y306‑p, ARHGAP5 iso3 (mouse): Y306‑p, ARHGAP5 (rat): Y305‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
mutation of modification site, phospho-antibody, western blotting
|
|
Relevant cell lines - cell types - tissues:
3T3-L1 (fibroblast), C2C12 (myoblast), MEF (fibroblast)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
mouse
|
|
Enzymes shown to modify site in vitro:
|
|
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
IGF-1
|
|
|
|
increase
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
intracellular localization
|
|
Effect of modification (process):
cell differentiation, altered
|